Univec is trading at 0.0037 as of the 28th of November 2024, a 23.33 percent increase since the beginning of the trading day. The stock's open price was 0.003. Univec has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Univec Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. The company was founded in 1992 and is based in Baltimore, Maryland. UNIVEC INC operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 181.21 M outstanding shares. More on Univec Inc
Univec Inc [UNVC] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Univec's market, we take the total number of its shares issued and multiply it by Univec's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Univec Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 181.21 M outstanding shares.
Univec Inc currently holds about 15.48 K in cash with (667.5 K) of positive cash flow from operations.
Check Univec Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Univec without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Theme Ratings Now
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Elected by the shareholders, the Univec's board of directors comprises two types of representatives: Univec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Univec. The board's role is to monitor Univec's management team and ensure that shareholders' interests are well served. Univec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Univec's outside directors are responsible for providing unbiased perspectives on the board's policies.
Other Information on Investing in Univec Pink Sheet
Univec financial ratios help investors to determine whether Univec Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Univec with respect to the benefits of owning Univec security.